🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
The main purpose of this study is to learn more about the safety and tolera...
Status
Completed
Location
MNJ Institute of Oncology
Start Date
2021-02-22
Trial ID
NCT04707196
Treatments Being Tested
Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Start Date
2017-11-09
Trial ID
NCT03425838
Treatments Being Tested
Multicenter, single-arm, open label, phase II clinical trial with safety ru...
Status
Terminated
Location
Complejo Hospitalario de Jaen
Start Date
2021-05-06
Trial ID
NCT04714619
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled study conducted in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-08-29
Trial ID
NCT03671330
Treatments Being Tested
To compare the combination of Ribociclib plus goserelin acetate with hormon...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-02-25
Trial ID
NCT03839823
The reason for this study is to see if the drug abemaciclib in combination ...
Status
Withdrawn
Location
Southern Cancer Center, P.C.
Start Date
2019-09-16
Trial ID
NCT03988114
Treatments Being Tested
Although randomized controlled trials (RCTs) provide evidence of efficacy, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-03-15
Trial ID
NCT02753686
The purpose of this study was to determine whether treatment with tamoxifen...
Status
Completed
Location
Comprehensive Blood and Cancer SC-2
Start Date
2014-11-20
Trial ID
NCT02278120
Treatments Being Tested